Viewing Study NCT00983528


Ignite Creation Date: 2025-12-26 @ 11:11 AM
Ignite Modification Date: 2026-01-14 @ 1:44 AM
Study NCT ID: NCT00983528
Status: TERMINATED
Last Update Posted: 2020-08-12
First Post: 2009-09-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic Leukemia
Sponsor: University of California, San Diego
Organization: